扫描下面的二维码:

二维码

"病毒性肝炎"标签列表

FibroSURE 和FIBROSpect II方法在丙肝纤维化分期检测中的应用2007-12-26

丙肝患者给与长效干扰素α-2a治疗2007-12-26

长效干扰素联合利巴韦林治疗无应答的非肝硬化丙肝患者2007-12-26

干扰素治疗复治丙肝患者的病毒学应答2007-12-26

ACCELERATE研究:未获得快速病毒学应答的基因2/3型丙肝患者治疗2007-12-26

Optimize HCV treatment to maximize cost- effectiveness 2007-12-10

Emerging therapy for chronic hepatitis C 2007-12-10

Treatment of Acute HCV Infection 2007-12-10

Management of Chronic hepatitis C in Special Populations Normal ALT, HIV Co-infection, Renal Failure2007-12-10

I have financial relationships within the last 12 months relevant to my presentation with: Bristol-M2007-12-06

Treatment Duration in Genotype 1 Patients: The Long and The Short of It2007-11-16

Current Treatment Concepts for Genotype 2/3 Patients and Nonresponding Patients2007-11-16

Practical Approaches to Side Effect Management2007-11-16

纹身是丙型肝炎病毒(HCV)感染的危险因素2007-11-16

欧盟批准佩乐能联合利巴韦林治疗干扰素或长效干扰素治疗不应答的丙肝这一新适应征2007-11-15

COPILOT试验:低剂量聚乙二醇干扰素α-2b治疗丙肝肝硬化的耐受性2007-11-15

聚乙二醇干扰素α-2b联合利巴韦林治疗ALT正常的慢性丙肝预测SVR2007-11-15

聚乙二醇干扰素α-2b联合利巴韦林治疗慢性丙肝病毒学应答评估2007-11-15

多因素分析结果:第四周的快速病毒学应答(RVR)是慢性丙肝的最佳预测因素2007-11-15

GET-C研究:超速病毒学应答(URVR)可以预测基因3型高载量丙肝的SVR2007-11-15

领域标签 >>



设为首页 | 加入收藏 | 网站地图 | 订阅杂志 | 关于我们 | 版权声明 | 联系方式|招贤纳士
国际肝病  版权所有  京ICP备15060708号   (京)-非经营性-2016-0001京公网安备 11010502033341号 2004-2020  www.ihepa.com  ALL Rights  Reserved

增值电信业务经营许可证:京B2-20212326

网站统计